US FDA approves Springworks' genetic disorder drug

SpringWorks Therapeutics

11/02/2025 20:57

Feb 11 (Reuters) - The U.S. Food and Drug Administration
on Tuesday approved Springworks Therapeutics'  SWTX.O  drug to
treat a type of rare genetic disorder that causes tumors to grow
on nerves throughout the body.
    

 (Reporting by Christy Santhosh in Bengaluru; Editing by
Mohammed Safi Shamsi)
 ((Christy.Santhosh@thomsonreuters.com;))